CannabisLink.ca - Current Affairs 2026

(2026) - Chronological (1593 items)

(All links open in new tab)

Sep 25, 2026	Curaleaf dismisses Aurora's securities complaint as "desperate delay tactics" Curaleaf has accused Aurora Cannabis of "desperate delay tactics that focus on technicalities" after Aurora took its objections to Curaleaf's hostile bid to the Alberta Securities Commission. Aurora filed the application on September 23, according to German outlet Hanfjournal, asking the regulator to order Curaleaf to correct its bid circular on three points: the absence of pro forma financial statements for the combined company, whether the bid stays open for the full minimum deposit period required by securities law, and the lack of notice in a French-language publication.
Sep 25, 2026	90% of Americans Want Legal Weed. Lawmakers in Both Parties Keep Punishing Them for It. Nearly 90% of Americans—including majorities of Democrats and Republicans—say that marijuana should be legal for either medical or adult use. Yet far too often, lawmakers choose to either ignore this constituency or treat them with outright hostility. In several Republican-led states, lawmakers have overturned (or are actively trying to overturn) voters’ decisions on cannabis policy, while in Democratic-led states, lawmakers are undermining existing legalization markets by drastically hiking marijuana-related taxes.
Sep 25, 2026	Dates announced for 10th Annual International Cannabis Business Conference For the last decade, the annual International Cannabis Business Conference (ICBC) in Berlin has served as the world's premier cannabis industry tradeshow. Legal cannabis markets have evolved considerably in the last ten years, particularly in Europe, and ICBC has been at the forefront of all of it. With ICBC set to return to Berlin on April 13th-15th, 2027, this year's tradeshow will be bigger and better than ever. It will not only be a celebration of the conference's 10th anniversary in Berlin, but also a celebration of how much progress the international cannabis industry has made in the last decade.
Sep 25, 2026	How Employers Are Adapting to Medical Cannabis in the Workplace More states have active medical cannabis programs than at any point in the past decade. That shift has moved a once-niche compliance question into ordinary HR conversations across a wide range of industries. A worker with a valid medical cannabis card still faces real friction on the job. Drug testing policies, safety-sensitive roles, and inconsistent state protections mean a legal patient can end up defending their treatment to a supervisor who has no framework for the conversation. It’s an awkward spot for everyone involved.
Sep 25, 2026	Switzerland’s SCRIPT Trial Finds Regulated Cannabis Sales Change How People Consume, Not How Much Government-led scientific studies from across Europe’s most progressive cannabis markets are solidifying an evidence base suggesting that greater access does not cause greater harm to public health. Building on Germany’s government-mandated Ekocan reports, officials in the Netherlands recently published their preliminary findings from the country’s ongoing adult-use cannabis experiment. Alongside these country-wide frameworks, Switzerland’s eight active regional pilot projects continue to provide unique and precisely targeted results.
Sep 25, 2026	Almost Three-Quarters Of Massachusetts Voters Oppose Ballot Measure To Roll Back Marijuana Legalization, Poll Shows Massachusetts voters overwhelmingly oppose an initiative on the November ballot that would roll back the state’s marijuana legalization law, according to a new poll. The survey, released on Thursday by The University of New Hampshire, shows that nearly three-quarters (71 percent) of respondents plan to vote against the anti-cannabis measure, while just 24 percent plan to support it.
Sep 24, 2026	Survey Finds Most German Cannabis Patients ‘Feel Stigmatized’ More patients in Germany are using legal medical cannabis to treat their condition(s) than ever before. However, an overwhelming percentage of them feel stigmatized in their daily lives because of it, according to a recent survey. MedCanOneStop (MCOS), a Düsseldorf-based medical cannabis digital infrastructure platform, surveyed 7,033 German medical cannabis patients, asking them about the effectiveness of their therapeutic use of cannabis, among other things. “70 percent of patients report massively improved sleep, and almost half are more productive and pain-free at work.” MCOS wrote in a news release (translated from German to English. “Over two-thirds of those surveyed were able to completely discontinue prescription painkillers, opiates, or sleeping pills thanks to cannabis.”
Sep 24, 2026	Chain vs. Indy: Which Dispensaries Do People Prefer? Dispensaries generally fall into one of two camps: part of a multi-state chain, or an independent operator. Those independents might own several stores within one state (a single-state operator), or they might be a classic “mom & pop” shop with a single location. Consumers have good reasons to shop at either, and sometimes it just comes down to location and convenience. However, when pressed, it seems renegade cannabis consumers prefer the indies.
Sep 24, 2026	The Netherlands’ Landmark Adult-Use Cannabis Experiment Publishes First Results Initial findings from the Netherlands’ landmark ‘controlled cannabis supply chain experiment’ were submitted to the House of Representatives on September 9, the first published findings since the T0 baseline report, published in March 2024 (covering data collected in 2022). The new data covers the period from April 7, 2025, through the first quarter of 2026, the first full year of fully regulated cannabis sales.
Sep 23, 2026	Mainstream insurance companies push for cannabis industry access Introduced on Sept. 16 by Democratic U.S. Rep. Nydia Velazquez of New York and Republican U.S. Rep. Warren Davidson of Ohio, the bill “would shield insurers, brokers and agents from federal penalties for serving state-licensed cannabis businesses,” the lawmakers said in a news release.
Sep 23, 2026	Maryland veterinarians soon may advise on cannabis for pets A law in Maryland taking effect next week will enable veterinarians in the state to discuss and recommend the use of cannabis products in pets without fear of sanctions. It's the first such state law to pass in four years, breaking a quiet legislative spell that's left advocates of clear regulatory guidance across the country discouraged. Beginning Oct. 1, practitioners in Maryland may advise clients on the safe use of over-the-counter cannabis-derived products. Until now, veterinarians who discussed such products with clients could face disciplinary action.
Sep 23, 2026	Alabama Withdraws its Opposition to Cannabis Rescheduling Federally Alabama public health regulators have withdrawn their opposition to the federal government’s decision to move medical cannabis into a lower drug schedule, marking a change in the state’s position as its long-delayed cannabis program gets underway. The Alabama Public Health Committee unanimously voted to rescind its opposition. The committee had rejected the federal shift in May, only weeks after the Justice Department issued its final order placing state-authorized medical marijuana in Schedule III.
Sep 23, 2026	The Generational Flip: Are Teens Ditching Weed While Seniors Are Using More? What the Latest US Data Shows Cannabis use among U.S. teens has declined substantially even as adult-use legalization has expanded, challenging predictions that regulated markets would necessarily drive higher consumption among young people. Meanwhile, national data show cannabis use rising among adults 65 and older, while a recent New York City study highlights both the reasons seniors are using it and the potential risks that come with that shift.
Sep 23, 2026	Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure EDMONTON, AB, Sept. 23, 2026 /PRNewswire/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, today filed an application with the Alberta Securities Commission ("ASC') for an order requiring Curaleaf Holdings, Inc. ("Curaleaf") (TSX: CURA) (OTCQX: CURLF) to address several deficiencies Aurora has identified in its hostile bid Circular and to require Curaleaf to comply with securities law requirements. "We believe Curaleaf has failed to comply with applicable securities law requirements in connection with its hostile bid, and Aurora intends to vigorously defend its interests and those of its shareholders. Aurora is taking the necessary steps to protect its shareholders' rights, which this hostile bid is clearly ignoring," said Miguel Martin, Executive Chairman and Chief Executive Officer of Aurora.
Sep 23, 2026	TobaGrown seeks answers after Steinbach cannabis petition rejected TobaGrown founder and CEO Jesse Lavoie says his organization plans to pursue legal and advocacy options after the City of Steinbach determined a petition seeking a plebiscite on cannabis retail did not meet the requirements to trigger a vote. The organization submitted 4,014 signatures to the City after more than 90 days of canvassing in Steinbach. Lavoie says the organization wants more information about that review before accepting the decision.
Sep 23, 2026	CDC Data Shows High School Cannabis Use At Record Low New data from the Centers for Disease Control and Prevention (CDC) shows that cannabis use among U.S. high schoolers is at the lowest level recorded since the agency started tracking the data in 1991. The data is from the 2025 Youth Risk Behavior Survey (YRBS), which anonymously monitors high school health-risk behaviors, including drug use. According to the results, 12.9% of high schoolers said they currently use cannabis, while 25.5% said they have used cannabis at least once.
Sep 23, 2026	Thailand Cabinet approves bill to restrict cannabis to medical use Thailand's cabinet approved a draft bill on September 22 to tighten control over its cannabis industry, pushing forward the government's reversal of the decriminalisation policy that took effect in 2022. Public Health Minister Pattana Promphat announced the bill, which strengthens oversight of cannabis cultivation and processing and increases penalties for violations. It now goes to parliament for consideration.
Sep 23, 2026	American hemp sellers prepare for a looming ban on most of their products: ‘This is devastating’ Beginning in December, new federal restrictions will make many hemp products illegal. Businesses in the industry are getting ready to close down most or all of their operations, while advocates hope there's still time to change course before the ban begins.
Sep 22, 2026	Cannabis DUI Policy Continues To Evolve In Australia Consumers and patients being falsely accused of driving under the influence (DUI) of cannabis is an important, but often overlooked, area of public policy. It is also an important consideration when it comes to the emerging legal cannabis industry. The industry’s consumer base is directly impacted by cannabis DUI policy and enforcement. Wherever there are discussions about cannabis commerce legalization and expansion, it is seemingly always coupled with discussions about DUI policy and enforcement.
Sep 22, 2026	CBD: Full-Spectrum Extracts Under Threat in Greece Greece is significantly tightening its regulations on CBD and hemp-derived products, requiring certain full-spectrum CBD oils and other natural extracts are set to disappear from the market. The new regulatory framework, outlined by the Greek Ministry of Health on September 15, significantly restricts the range of cannabinoids that can be sold legally and could transform the hemp industry in the country.

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80